R-Hyper-CVAD Regimen

Preferred Label : R-Hyper-CVAD Regimen;

NCIt synonyms : Rituximab and Hyperfractionated Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone Regimen; R-Hyper-CVAD; Hyper-CVAD Plus Rituximab; Rituximab Plus HyperCVAD; R-HCVAD; Rituximab-HyperCVAD;

NCIt related terms : R-HyperCVAD;

NCIt definition : A regimen consisting of cyclophosphamide, vincristine, doxorubicin and dexamethasone, administered on a hyperfractionated schedule, plus rituximab that is used to treat some types of non-Hodgkin lymphoma (NHL), including mantle cell lymphoma, and acute lymphoblastic leukemia (ALL).;

NCI Metathesaurus CUI : CL538180;

Details

Origin ID

C140104;

UMLS CUI

C4682705;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Dexamethasone [NCIt concept]
- Doxorubicin [NCIt concept]
- Rituximab [NCIt concept]
- Vincristine [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database-Regimen [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients